Carlos Singer

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi request reprint A case of painless arms/moving fingers responsive to botulinum toxin a injections
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 13:55-6. 2007
  2. ncbi request reprint A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miami, Florida, USA
    Mov Disord 22:476-82. 2007
  3. ncbi request reprint A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, and Massachusetts General Hospital, Boston, USA
    Mov Disord 22:1664-6. 2007
  4. doi request reprint Comprehensive treatment of Huntington disease and other choreic disorders
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Cleve Clin J Med 79:S30-4. 2012
  5. doi request reprint Managing the patient with newly diagnosed Parkinson disease
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Clinical Research Building, Leonard M Miller School of Medicine, University of Miami, 1120 NW 14th Street, 13th Floor, Miami, FL 33136, USA
    Cleve Clin J Med 79:S3-7. 2012
  6. ncbi request reprint Primary writing tremor: report of a case successfully treated with botulinum toxin A injections and discussion of underlying mechanism
    Carlos Singer
    Department of Neurology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:1387-8. 2005
  7. ncbi request reprint Lower limb post-immobilization dystonia in Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miller School of Medicine, School of Medicine 1501 NW 9th Avenue Miami, FL 33136, USA
    J Neurol Sci 239:111-4. 2005
  8. ncbi request reprint A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia
    Carlos Singer
    Miller School of Medicine, Department of Neurology University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:115-8. 2006
  9. ncbi request reprint Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder
    C Singer
    Department of Neurology, University of Miami School of Medicine, 1501 NW 9 Ave, Miami, FL 33136, USA
    Neurology 64:2156-7. 2005
  10. ncbi request reprint Cervical dystonia: etiology and pathophysiology
    Carlos Singer
    Division of Movement Disorders, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Neurol Clin 26:9-22. 2008

Research Grants

Detail Information

Publications66

  1. ncbi request reprint A case of painless arms/moving fingers responsive to botulinum toxin a injections
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 13:55-6. 2007
    ..The presence of dystonic symptoms in our case argues in favor of a possible implication of a dystonic mechanism in at least some cases of PLME...
  2. ncbi request reprint A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miami, Florida, USA
    Mov Disord 22:476-82. 2007
    ..Noninferiority of sumanirole to ropinirole was not demonstrated, with a difference of 2.70 (90% CI, 0.92-4.49). Sumanirole was better tolerated than ropinirole...
  3. ncbi request reprint A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, and Massachusetts General Hospital, Boston, USA
    Mov Disord 22:1664-6. 2007
    ..Physician awareness of this rare syndrome may lead to its better characterization and management...
  4. doi request reprint Comprehensive treatment of Huntington disease and other choreic disorders
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    Cleve Clin J Med 79:S30-4. 2012
    ..Caring for the caregiver is also a significant concern in the long-term treatment of choreic disorders...
  5. doi request reprint Managing the patient with newly diagnosed Parkinson disease
    Carlos Singer
    Center for Parkinson s disease and Movement Disorders, Clinical Research Building, Leonard M Miller School of Medicine, University of Miami, 1120 NW 14th Street, 13th Floor, Miami, FL 33136, USA
    Cleve Clin J Med 79:S3-7. 2012
    ..Deep brain stimulation may slow cognitive and motor decline when used in early PD. Stem cell therapy and gene therapy are still under investigation...
  6. ncbi request reprint Primary writing tremor: report of a case successfully treated with botulinum toxin A injections and discussion of underlying mechanism
    Carlos Singer
    Department of Neurology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:1387-8. 2005
    ..We describe a patient with PWT, present a video before and after successful treatment with botulinum toxin type A injections, and discuss a possible underlying dystonic mechanism...
  7. ncbi request reprint Lower limb post-immobilization dystonia in Parkinson's disease
    Carlos Singer
    Department of Neurology, University of Miami, Miller School of Medicine, School of Medicine 1501 NW 9th Avenue Miami, FL 33136, USA
    J Neurol Sci 239:111-4. 2005
    ..Post-immobilization dystonia of lower limbs in PD is resistant to medical treatment and leads to significant functional disability. Botulinum toxin may provide partial relief in some cases and orthopedic surgery can also be considered...
  8. ncbi request reprint A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia
    Carlos Singer
    Miller School of Medicine, Department of Neurology University of Miami, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:115-8. 2006
    ..Male gender, orobuccolingual dyskinesias (facial grimacing, lip biting, tongue dyskinesias, platysma contractions and bruxism) and better response to botulinum toxin injections were more frequent in C-OMD but remained a trend...
  9. ncbi request reprint Pontine/extrapontine myelinolysis occurring in the setting of an eating disorder
    C Singer
    Department of Neurology, University of Miami School of Medicine, 1501 NW 9 Ave, Miami, FL 33136, USA
    Neurology 64:2156-7. 2005
  10. ncbi request reprint Cervical dystonia: etiology and pathophysiology
    Carlos Singer
    Division of Movement Disorders, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Neurol Clin 26:9-22. 2008
  11. ncbi request reprint Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series
    Carlos Singer
    Department of Neurology University of Miami, School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:873-7. 2005
    ..Our results demonstrate that rimantadine may be considered as an alternative to amantadine in patients experiencing amantadine-induced peripheral side effects...
  12. pmc The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
    ..Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD...
  13. ncbi request reprint Melatonin MT1 and MT2 receptor expression in Parkinson's disease
    Nikhil Adi
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Med Sci Monit 16:BR61-7. 2010
    ..Although the role of melatonin, a potent endogenous antioxidant, has been highlighted in PD there is no data on the expression of melatonin receptors in affected CNS regions...
  14. doi request reprint Objective tremor registration during DBS surgery for essential tremor
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, United States
    Clin Neurol Neurosurg 111:376-9. 2009
    ..Simple electronic tremor registration methods during DBS of the Vim nucleus of the thalamus may supplement the existing methodology that is solely based on subjective measures derived from clinical observations...
  15. doi request reprint Giant arteriovenous malformation presenting as pediatric task-specific dystonia
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Miami, FL 33136, USA
    Neurology 70:1294. 2008
  16. ncbi request reprint Adult-onset primary focal foot dystonia
    Carlos Singer
    Department of Neurology, Miller School of Medicine, University of Miami, 1501 NW 9th Avenue, Miami, FL 33136, USA
    Parkinsonism Relat Disord 12:57-60. 2006
    ..Focal primary focal foot dystonia seems to be a rare form of focal dystonia with distinct clinical features that may benefit from treatment with botulinum toxin...
  17. doi request reprint Is the G2019S LRRK2 mutation common in all southern European populations?
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    J Clin Neurosci 15:1027-30. 2008
    ..Accurate estimations of the frequency and penetrance of different LRRK2 mutations are essential for correct and cost-efficient use of genetic testing and proper genetic counseling of patients with Parkinson's disease...
  18. ncbi request reprint Case of pediatric acquired chronic hepatocerebral degeneration
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Pediatr Neurol 38:67-70. 2008
    ..The pediatric phenotype of acquired chronic hepatocerebral degeneration is presented, and the differential diagnosis in regard to Wilson's disease and management alternatives are discussed...
  19. pmc Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL, USA
    Head Face Med 2:47. 2006
    ..We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction...
  20. ncbi request reprint Anterocollis: clinical features and treatment options
    Spiridon Papapetropoulos
    Department of Neurology, Division of Movement Disorders, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Med Sci Monit 14:CR427-30. 2008
    ..It has been mainly described in the context of parkinsonian movement disorders including Parkinson's disease and multiple system atrophy...
  21. ncbi request reprint Botulinum toxin in movement disorders
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida 33136, USA
    Semin Neurol 27:183-94. 2007
    ..However, controlled studies for many conditions are lacking, and more clinical trials in many different areas are warranted...
  22. pmc Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease
    Rodger J Elble
    Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
    Mov Disord 25:1082-6. 2010
    ..We found the investigators' level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment...
  23. ncbi request reprint Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami FL, 33136, USA
    J Neuropsychiatry Clin Neurosci 18:113-6. 2006
    ..Findings suggest that positive family history for dementia is associated with DLB with a yet unknown mechanism...
  24. ncbi request reprint Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors
    Spiridon Papapetropoulos
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Eur Neurol 59:71-5. 2008
    ..7%). Of patients injected with botulinum toxin type A, 24.5% reported excellent, 32.1% moderate, 16.9% mild and 24.5% no response to injections. Oral antidystonic medications had limited contribution to symptom relief...
  25. ncbi request reprint Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Clin Neuropharmacol 29:364-7. 2006
    ..One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl...
  26. ncbi request reprint Painless legs moving toes in a patient with Wilson's disease
    Spiridon Papapetropoulos
    Department of Neurology University of Miami, Miller School of Medicine, FL 33136, USA
    Mov Disord 21:579-80. 2006
    ..We suggest that, in our case, a structural central nervous system lesion caused by WD may have been associated with the development of PLMT...
  27. doi request reprint Gene-environment interactions in Parkinson's disease and other forms of parkinsonism
    Jeffery M Vance
    University of Miami, Miami, FL 33101, USA
    Neurotoxicology 31:598-602. 2010
    ..Thus, toxicant-alpha-synuclein interactions could have deleterious consequences and play a role in pathogenetic processes in human parkinsonism...
  28. doi request reprint A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis
    Michael Hoosien
    University of Miami, Miami, FL, 33136, USA
    J Neurooncol 101:135-9. 2011
    ....
  29. ncbi request reprint Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, School of Medicine, Miami, Florida 33136, USA
    Mov Disord 20:1380-3. 2005
    ..Maternally transmitted very large trinucleotide repeats (>100) are extremely rare in juvenile HD and may represent instability during female gametogenesis...
  30. pmc A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
    Spiridon Papapetropoulos
    Divisions of Movement Disorders Department of Neurology, University of Miami, Miller School of Medicine Miami, FL, USA
    BMC Neurol 8:21. 2008
    ..To this end, we developed the University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ) that allows comprehensive assessment of hallucinations in clinical or research settings...
  31. ncbi request reprint [Parkinsonism: alternative diagnosis beyond idiopathic Parkinson's disease]
    Jose Gutierrez
    Leonard M Miller School of Medicine, Department of Neurology, University of Miami, USA
    Rev Med Inst Mex Seguro Soc 48:279-92. 2010
    ..This review gives a general landscape of Parkinsonism and its most likely differentials...
  32. doi request reprint Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques
    Kathryn K Post
    Division of Movement Disorders, Department of Neurology, University of Miami, Miller School of Medicine, Clinical Research Building, 1120 N W 14th Street, 13th Floor, Room 1349, Miami, FL 33136, USA
    Parkinsonism Relat Disord 14:524-31. 2008
    ..We give one possible example of such a variable in this paper using heart transplant patients as a model...
  33. pmc SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease
    Lina A Shehadeh
    Department of Molecular and Cellular Pharmacology, University of Miami Leonard M Miller School of Medicine, Miami, Florida, United States of America
    PLoS ONE 5:e9104. 2010
    ..The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms...
  34. pmc Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study
    Christopher F McNicoll
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, Massachusetts 02118, USA
    Mov Disord 23:1596-601. 2008
    ..No relation between the HD CAG repeat size and the age at onset for PD was found in this sample of familial PD...
  35. pmc Objective quantification of neuromotor symptoms in Parkinson's disease: implementation of a portable, computerized measurement tool
    Spyridon Papapetropoulos
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Parkinsons Dis 2010:760196. 2010
    ..More work is warranted to establish CATSYS as a diagnostic/monitoring instrument in movement disorders using the proposed technical approaches...
  36. ncbi request reprint Childhood-onset hemifacial spasm: successful treatment with botulinum toxin
    Carlos Singer
    Department of Neurology, University of Miami, School of Medicine, Miami, Florida 33136, USA
    Pediatr Neurol 33:220-2. 2005
    ..This report presents the first case of a pediatric patient with childhood-onset hemifacial spasm successfully treated with periorbital botulinum toxin injections. The literature on the subject is also reviewed...
  37. doi request reprint Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes
    Robert Lopez-Alberola
    Dept of Pediatrics, University of Miami, Miller School of Medicine, Miami 33136, USA
    J Neurol 256:396-404. 2009
    ..Against this background we conducted a study aiming to elucidate the clinical characteristics, describe laboratory/ neuroimaging findings (MRI, PET) and present treatment options and outcomes in sporadic EL...
  38. ncbi request reprint Clinical heterogeneity of the LRRK2 G2019S mutation
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami School of Medicine, Miami, FL, USA
    Arch Neurol 63:1242-6. 2006
    ..The "common" LRRK2 G2019S kinase domain substitution has been reported to account for approximately 5% of familial and 1% of sporadic Parkinson disease...
  39. ncbi request reprint Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP)
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Parkinsonism Relat Disord 11:459-63. 2005
    ..Deaths that occurred during winter and spring months accounted for about 70% of deaths among PSP patients. The most common co-morbid condition in PSP was hypertension, present in 50% of cases...
  40. ncbi request reprint Primary craniocervical dystonia presenting as a respiratory emergency
    Spiridon Papapetropoulos
    Department of Neurology, University of Miami, Miller School of Medicine, 1501 NW 9th Avenue NPF, Room 4004, Miami, FL 33136, USA
    Neurology 68:388-9. 2007
  41. ncbi request reprint Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study
    Samer Karamohamed
    Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
    Mov Disord 20:1188-91. 2005
    ..None of the variants were found in the GenePD families. Our results suggest that other variants or genes account for the familial risk of PD within the GenePD study...
  42. doi request reprint Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson's disease?
    Corneliu C Luca
    Department of Neurology, Movement Disorders Division, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Parkinsonism Relat Disord 19:777-82. 2013
    ....
  43. pmc Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease
    Todd L Edwards
    John P Hussman Institute for Human Genomics, University of Miami, FL 33136, USA
    Ann Hum Genet 74:97-109. 2010
    ..79] T vs. C allele, PAR%= 8%) were genome-wide significant. No other SNPs were genome-wide significant in this analysis. This study confirms that SNCA and the MAPT region are major genes whose common variants are influencing risk of PD...
  44. pmc PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study
    Anita L Destefano
    Department of Neurology, Boston University Schools of Medicine and of Public Health, Boston, MA 02118, USA
    Am J Hum Genet 70:1089-95. 2002
    ....
  45. doi request reprint Treatment of painful limbs/moving extremities with botulinum toxin type A injections
    Mahmood Eisa
    Eur Neurol 60:104-6. 2008
  46. ncbi request reprint Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis
    Carlos Singer
    Mov Disord 22:289. 2007
  47. ncbi request reprint Lower facial and neck dystonia after a cosmetic surgical procedure: report of a case
    Spiridon Papapetropoulos
    Mov Disord 21:125-6. 2006
  48. ncbi request reprint Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)
    Spiridon Papapetropoulos
    Mov Disord 20:1088-9. 2005
  49. ncbi request reprint Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease?
    Spiridon Papapetropoulos
    Mov Disord 20:641-2. 2005
  50. ncbi request reprint Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study
    Daniel Truong
    The Parkinson s and Movement Disorders Institute, Fountain Valley, California 92708, USA
    Mov Disord 20:783-91. 2005
    ..These results confirm previous reports that Dysport (500 units) is safe, effective, and well-tolerated in patients with cervical dystonia...
  51. pmc Replication of association between ELAVL4 and Parkinson disease: the GenePD study
    Anita L Destefano
    Department of Biostatistics, Boston University School of Public Health, 715 Albany Street, Crosstown Center, 3rd Floor, Boston, MA 02118, USA
    Hum Genet 124:95-9. 2008
    ..This replication of association with rs967582 in a third cohort further implicates ELAVL4 as a PD susceptibility gene...
  52. ncbi request reprint Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study
    Mei Sun
    Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Arch Neurol 63:826-32. 2006
    ..The PARK2 gene at 6q26 encodes parkin, whose inactivation is implicated in an early-onset autosomal recessive form of Parkinson disease (PD)...
  53. ncbi request reprint Tardive dystonia associated with ziprasidone
    Spiridon Papapetropoulos
    Am J Psychiatry 162:2191. 2005
  54. ncbi request reprint Improvement of cervico-trunco-brachial segmental dystonia with topiramate
    Spiridon Papapetropoulos
    J Neurol 253:535-6. 2006
  55. ncbi request reprint Primary focal lingual dystonia
    Spiridon Papapetropoulos
    Mov Disord 21:429-30. 2006
  56. ncbi request reprint Bilateral mirror writing movements (mirror dystonia) in a patient with writer's cramp: Functional correlates
    Spiridon Papapetropoulos
    Mov Disord 22:149. 2007
  57. ncbi request reprint Pain-pressure threshold in patients with Parkinson's disease with and without dyskinesia
    Lydia Vela
    Unit of Neurology, Fundacion Hospital Alcorcon, C Budapest, Alcorcon 28922, Madrid, Spain
    Parkinsonism Relat Disord 13:189-92. 2007
    ..No differences were found in PPT between controls and PD patients with or without dyskinesia. Patients and control women had a lower PPT than men. In conclusion, the presence of dyskinesia in PD patients does not appear to decrease PPT...
  58. ncbi request reprint Cervical dystonia as a presenting symptom of Parkinson's disease
    Spiridon Papapetropoulos
    Parkinsonism Relat Disord 12:514-6. 2006
  59. ncbi request reprint Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease
    Spiridon Papapetropoulos
    Mov Disord 22:1670-1. 2007
  60. ncbi request reprint Sporadic geniospasm (chin trembling): report of a case
    Spiridon Papapetropoulos
    Mov Disord 22:434. 2007
  61. ncbi request reprint Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease
    William B White
    Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center and Clinical Trials Unit, University of Connecticut, Farmington, Connecticut 06030 3940, USA
    Hypertension 52:587-93. 2008
    ..3%, 2.6%, and 2.9% of the placebo, 0.5-mg, and 1.0-mg rasagiline groups, respectively. These data demonstrate that rasagiline did not induce postprandial hypertension in patients with Parkinson disease who were on an unrestricted diet...
  62. ncbi request reprint Moving fingers associated with Dupuytren's disease: a case report
    Spiridon Papapetropoulos
    Eur Neurol 59:96-7. 2008
  63. ncbi request reprint Staged unilateral or bilateral STN-DBS?
    Spiridon Papapetropoulos
    Mov Disord 23:775. 2008
  64. doi request reprint A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage
    Blake K Scanlon
    Parkinsonism Relat Disord 14:379-80. 2008
  65. pmc Caffeine and progression of Parkinson disease
    David K Simon
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Clin Neuropharmacol 31:189-96. 2008
    ..We assessed this relationship using data from 2 recent clinical trials of PD...

Research Grants3

  1. U of Miami PD Neuroprotection Clinical Trial Center
    Carlos Singer; Fiscal Year: 2002
    ..The University of Miami Parkinson's Disease Center is willing and dedicated to adhere to a common protocol and to cooperate with other centers and NINDS in the conduct of both pilot studies and the main efficacy study. ..
  2. U of Miami PD Neuroprotection Clinical Trial Center
    Carlos Singer; Fiscal Year: 2007
    ..The University of Miami Parkinson's Disease Center is willing and dedicated to adhere to a common protocol and to cooperate with other centers and NINDS in the conduct of both pilot studies and the main efficacy study. ..